Back
State Bank of India Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
60
SBKFF
State Bank of India
Last Price:
$85.00
Seasonality Move:
5.07%
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
$73.40
Seasonality Move:
14.66%
Buy
60
State Bank of India (SBKFF)
is a Buy
Is State Bank of India a Buy, Sell or Hold?
-
The current State Bank of India [SBKFF] share price is $85.00. The Score for SBKFF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
SBKFF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $79.97. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SBKFF Stock Price Chart
What is State Bank of India's stock price today?
-
The State Bank of India share price today is $85.00The current trend is relatively stagnant and SBKFF is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $79.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SBKFF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.17 | Buy |
Relative Strength Index (14 RSI): | 55.09 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (79.51 - 85.29) | Buy |
Bollinger Bands (100): | (82.53 - 98.37) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.65 | Sell |
Relative Strength Index (14 RSI): | 30.31 | Sell |
Chaikin Money Flow: | 3301090 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (94.25 - 111.51) | Sell |
Bollinger Bands (100): | (105.8 - 127.52) | Sell |
SBKFF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.9 | Sell |
20-day SMA: | 82.81 | Buy |
50-day SMA: | 83.27 | Buy |
200-day SMA: | 95.12 | Sell |
8-day EMA: | 85.91 | Sell |
20-day EMA: | 84 | Buy |
50-day EMA: | 85.09 | Sell |
200-day EMA: | 89.45 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.24 | Sell |
20-day SMA: | 101.11 | Sell |
50-day SMA: | 110.69 | Sell |
200-day SMA: | 125.58 | Sell |
8-day EMA: | 91.61 | Sell |
20-day EMA: | 99.38 | Sell |
50-day EMA: | 107.77 | Sell |
200-day EMA: | 119.29 | Sell |
State Bank of India Earnings Growth & SBKFF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
State Bank of India Technical Analysis
Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |